[BrightGene Biotech] Announcement of Board of Directors' Approval of First Quarter 2026 Consolidated Financial Report

1. Date of submission to or resolution by the Board of Directors: 115/05/12 2. Date of approval by the Audit Committee: 115/05/12 3. Reporting period for financial report or annual self-assessed financial information (Start Date ~ End Date): 115/01/01~115/03/31 4. Cumulative operating revenue from January 1 to this period (in thousands of NT$): 84,385 5. Cumulative gross profit (loss) from January 1 to this period (in thousands of NT$): 64,455 6. Cumulative operating income (loss) from January 1 to this period (in thousands of NT$): 25,464 7. Cumulative profit (loss) before tax from January 1 to this period (in thousands of NT$): 27,985 8. Cumulative net profit (loss) for the period from January 1 to this period (in thousands of NT$): 23,944 9. Cumulative net profit (loss) attributable to owners of the parent from January 1 to this period (in thousands of NT$): 23,944 10. Cumulative basic earnings per share (loss) from January 1 to this period (in NT$): 0.97 11. Total assets at end of period (in thousands of NT$): 726,709 12. Total liabilities at end of period (in thousands of NT$): 98,435 13. Equity attributable to owners of the parent at end of period (in thousands of NT$): 628,274 14. Other matters that should be noted: None. Keywords: Important Information *Company Business: (Assumed based on typical press releases of this nature, no specific info provided in original text)* The company likely operates in the biotechnology and pharmaceutical sector, focusing on R&D for new drugs and treatments. *Official URL: (Not provided in original text)* *Address: (Not provided in original text)* *Established: (Not provided in original text)* *Capital: (Not provided in original text)* *Employees: (Not provided in original text)* *CEO: (Not provided in original text)* *Business Description: (Assumed)* Engaged in the research, development, and commercialization of innovative biopharmaceutical products and therapeutic solutions for unmet medical needs. *Image Description: (Not applicable, no image provided)* *Alt JA: (Not applicable)* *Alt EN: (Not applicable)* *Alt ZH: (Not applicable)*